v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Jul. 31, 2026
Jul. 25, 2025
Income Statement [Abstract]    
Net sales $ 843 $ 723
Cost of products sold 378 314
Gross profit 465 409
Operating expenses:    
Research and development expense 115 125
Selling, general, and administrative expense 312 283
Certain litigation charges, net (2) 17
Other operating expense (income), net 36 (2)
Operating income (expense) 5 (13)
Other non-operating expense (income), net 0 0
Income (loss) before income taxes 4 (13)
Income tax provision 4 3
Net income (loss) 0 (16)
Net income attributable to noncontrolling interests 0 (3)
Net income (loss) attributable to the Company $ 0 $ (19)
Earnings (loss) per share:    
Earnings (loss) per share, basic (in dollars per share) $ 0.00 $ (0.08)
Earnings (loss) per share, diluted (in dollars per share) $ 0.00 $ (0.08)
Weighted-average shares outstanding    
Basic weighted average shares outstanding (in shares) 281.0 252.8
Diluted weighted average shares outstanding (in shares) 281.0 252.8